Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)
NCT02926456
·
clinicaltrials.gov ↗
COMPLETED
Status
337
Enrollment
INDUSTRY
Sponsor class
Conditions
Human Immunodeficiency Virus
Sponsor
Janssen-Cilag S.p.A.